Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis CEtsuro Orito, Johnson Y.N. Lau, K. Hayashi et al.|Journal of Medical Virology|1995Cited by 104
Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trialIvan Fan‐Ngai Hung, Kwok‐Yung Yuen, Jinxia Zhang et al.|The Lancet Infectious Diseases|2015Cited by 82
Three different GB virus C/hepatitis G virus genotypesMotokazu Mukaide, Johnson Y.N. Lau, Masashi Mizokami et al.|FEBS Letters|1997Cited by 65